Margret Schottelius
Papers
1
Total Citations
21
H-Index
1
About
Margret Schottelius is a leading figure in theranostics, with a primary focus on developing targeted molecular probes for prostate cancer imaging and therapy. Her seminal work on PSMA (prostate-specific membrane antigen) theranostics has been pivotal, most notably in the 2016 study demonstrating the combined use of PET imaging and subsequent radioguided surgery for recurrent prostate cancer. This highly cited paper (21 citations) exemplifies her core contribution: bridging diagnostic precision with therapeutic intervention. Schottelius’s research centers on designing and validating novel radiotracers that enable simultaneous detection and targeted treatment of malignancies, significantly advancing the field of personalized oncology. Her achievements include pioneering the clinical translation of PSMA-targeted agents, which have since become standard tools in nuclear medicine. Through her innovative approach, Schottelius has not only improved patient outcomes by enabling more accurate staging and surgical guidance but also set a benchmark for theranostic strategies in other cancers. Her work continues to inspire a new generation of researchers exploring the intersection of chemistry, imaging, and therapy.
Research Focus
Key Achievements
Top Papers
- 1